;">
Limited Ed. "Visionary Synthesis" Diptych
Get a numbered photographic print, signed by Sasha Shulgin, when you contribute


Bupropion Basics
by Erowid




BUPROPION IMAGES
DESCRIPTION
Bupropion is a pharmaceutical, prescription antidepressant which acts directly on the brain and other nerve cells. Bupropion is considered a 'second generation' or 'atypical' anti-depressant because its action is different from the previous generation of psychoactive medications. It was first introduced in the US in 1985 but was quickly withdrawn because of the high incidence of seizures, it was reintroduced in 1989 at a much lower prescription dose. It is generally found stimulating by users and reactions to it vary greatly, with some users experiencing panic attacks and other acute negative reactions to the drug.

Bupropion is sold both as an antidepressant in the US under the trade name "Wellbutrin" and as an aid for quitting smoking under the trade name "Zyban". Bupropion hydrochloride is a white crystalline powder which is highly water soluble, has a bitter taste, and has a local anaethestic effect on oral mucosa (much like cocaine).
[ Main Bupropion Vault ]

Dose
Typicaly 75-300mg daily with a maximum prescription of 450mg daily approved by the FDA due to increasing risk of seizure with higher doses. Sold in pills of 75 & 100mg and 100 & 150mg time release.

Price
$1-3 USD per day in the United States.

Law
Bupropion is not scheduled in the United States, but is legal for sale for human consumption only with a prescription or license.

Chemistry
Bupropion is an aminoketone, chemicaly related to other phenethylamines, a class of molecule that contains a number of psychoactive chemicals.

Pharmacology / Mechanism of Action
The exact mechanism of action of bupropion is not currently known. In rats, chronic stress leads to increased levels of tyrosine hydroxylase (a key enzyme in norepinephrine synthesis) in the locus coeruleus (LC). Chronic use of bupropion, as well as many antidepressants, shows decreased expression of tyrosine hydroxylase in the LC. Other known mechanisms of action of bupropion are that it is a weak inhibitor of neuronal norepinephrine, serotonin and dopamine uptake. Because its inhibition of serotonin reuptake is weak and because it also inhibits the re-uptake of norepinephrine and dopamine, bupropion is not generally classified as an SSRI.

Bupropion selectively inhibits dopamine reuptake, much like cocaine, but, arguably, without the reinforcing effects. It has been used to treat children with ADHD, but there is a high incidence of severe skin rashes when used in this manner. It has also been effective in the treatment of smoking cessation (under the trade name Zyban). Unlike many antidepressants, Bupropion is not used to treat panic attacks, however, patients who have suffered sexual dysfunction as a result of serotonin-specific reuptake inhibitors may show some improvement if switched to bupropion. Its ability to treat cocaine addiction appears promising, though controversial. Bupropion is not an MAOI.

History
First developed in the late 1970's it was first approved for sale in the United States in 1985 but quickly removed from the market in 1986 due to problems with seizures in patients. In 1989, Bupropion was placed back on the market in the United States at a lower recommended dose.

Slang / Brands
Amfebutemone; Bupropion; Wellbutrin (as anti-depressant); Zyban (as nicotine addiction treatment)


EFFECTS
General
Bupropion appears to resemble behavioral stimulants more than it resembles antidepressants. Effects can include anxiety, restlessness, tremor and insomnia. Some users have reported that it can alleviate cravings for amphetamines and has been used to replace amphetamine in some cases of depression and ADHD.

Onset
Acute effects can generally be felt within 60-90 minutes of administration, but long term antidepressant effects may take days or weeks to develop.

Duration
Users report that stimulation can last for 12-24 hours or longer after a single dose, active metabolites have half-lives of 20-34 hours.

Side Effects
Restlessness, insomnia, anxiety reactions, discomfort, unpleasant stimulation, dry mouth, dizzyness / nausea, headaches, tremors.


PROBLEMS

Adverse Reactions
"The Australian Adverse Drug Reactions Advisory Committee has received 780 reports in association with bupropion to mid-May 2001. The more commonly reported problems have involved skin reactions (307 reports), psychological disturbances (285) and nervous system disorders (268). Urticaria [hives, skin rashes] has been the most common event reported (167 reports). Other reactions commonly reported have included nausea (87 reports), dizziness/ataxia (78), other rashes (86), insomnia (78), headache (68), and tremor (57)." From ADRAC

Seizure
There is a very serious, though not common, effect associated with bupropion, however. It may induce de novo seizures, meaning that even someone with no history -- family or otherwise -- of seizures, may respond to bupropion in this way, especially at higher doses.

The incidence of seizures is dose dependent:
This seizure incidence exceeds that of other marketed antidepressants. Immediate release formulas (not SR, sustained release) appear to promote higher risk of seizures. In addition, patients who have or have had anorexia nervosa or bulimia are at a higher risk of seizures.

Addiction Potential
Abrupt cessation of chronic administration of buproprion is not advised and slow tapering off is recommended, as with all chronically administered anti-depressants.

Contraindications



Last Modified - Tue, Apr 24, 2007 Created by Erowid

[ Back to Bupropion Vaults ] [ Back to Pharmaceuticals Vaults ]
[Plants & Drugs] [Mind & Spirit] [Freedom & Law] [Arts & Sciences] [Library] [Search] [About]
(content and html © 1995-2008 Erowid.org. Please ask permission before publicly reproducing.)
Erowid.org Plants & Drugs Mind & Spirit Freedom & Law Arts & Sciences Search About Erowid and Feedback Library & Bookstore Copyrights Memberships